Community Engagement for Type II Diabetes Prevention

Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors

Recruiting N/A Interventional Study
Type II Diabetes Mellitus
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 and older
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
240 (estimated)
Sponsor
Baqai Institute of Diabetology and Endocrinology · Other
Who this trial is looking for

This trial is looking for people aged 20 and older living in Karachi, Pakistan, to take part in efforts to prevent and control Type II diabetes. Participants will attend meetings and activities designed to help with this goal.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am 20 years old or older.
  • I live in Karachi, Pakistan.
  • I agree to participate in the study.
  • I have normal blood sugar, borderline high blood sugar, or diabetes.
  • I can attend scheduled meetings and activities.

You may not be able to join if

  • I am under 20 years old.
  • I do not want to give my consent to participate.
  • I have severe health issues that would keep me from joining in.
  • I cannot follow the study's rules.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This project aims to adapt, implement, and evaluate PLA based intervention in urban Karachi, Pakistan for TIIDM prevention and control.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Individuals aged 20 years and above. * Participants residing in the randomized clusters of Karachi, Pakistan * Individuals willing to participate in the study and provide consent. * Both individuals with normoglycemia, intermediate hyperglycemia, and diabetes are encouraged to…
Contacts

Abdul Basit, Director

922136688897

abdulbasit@bide.edu.pk

CONTACT

Rubia Zafar, TrialManager

rzafar@bide.edu.pk

CONTACT